Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy” (GROWTH CD) Study
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy” (GROWTH CD) Study
A. Levine,D. Turner,13 Authors,M. Sładek
2014 · DOI: 10.1097/01.MIB.0000437735.11953.68
Inflammatory Bowel Diseases · 95 Citations
TLDR
Normal CRP steroid-free remission at week 12 was impacted by type of induction therapy, but not by early immunomodulation, and was associated with more corticosteroids-free therapy at week 52 and a trend for less relapses.